Registrars: | Capita Registrars |
CEO: | Nigel Theobald |
Executive Director: | David Templeton |
Executive Director: | Luke Cairns |
Non-Executive Chairman: | Chris Britten |
Non-Executive Dir: |
Address: | 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR |
Website: | http://www.n4pharma.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYW8QM32 |
Currency | UK Pounds |
Share Price | 0.83p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 3.07 |
52 Week Low | 0.80 |
Volume | 3,285,001 |
Shares Issued | 268.78m |
Market Cap | £2.22m |
Value |
---|
Value |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:15 | 900,000 @ 0.84p |
15:54 | 26,000 @ 0.80p |
15:54 | 124 @ 0.80p |
12:50 | 59,192 @ 0.84p |
12:50 | 30,000 @ 0.84p |
You are here: research